Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 1572045-62-5
2. Rezvilutamide [inn]
3. Unii-70fjn2aw22
4. 70fjn2aw22
5. Ariane
6. Shr3680
7. Rezvilutamide [who-dd]
8. 4-[3-[4-[(2s)-2,3-dihydroxypropoxy]phenyl]-4,4-dimethyl-5-oxo-2-sulfanylideneimidazolidin-1-yl]-2-(trifluoromethyl)benzonitrile
9. Shr-3680
10. 4-(3-(4-((s)-2,3-dihydroxypropoxy)phenyl)-4,4-dimethyl-5-oxo-2-thioxoimidazolidin-1-yl)-2-(trifluoromethyl)benzonitrile
11. Benzonitrile, 4-(3-(4-((2s)-2,3-dihydroxypropoxy)phenyl)-4,4-dimethyl-5-oxo-2-thioxo-1-imidazolidinyl)-2-(trifluoromethyl)-
12. Example 44 [wo2014036897a1]
13. Example 44 (wo2014036897a1)
14. 4-(3-(4-((2s)-2,3-dihydroxypropoxy)phenyl)-4,4-dimethyl-5-oxo-2-sulfanylideneimidazolidin-1-yl)-2-(trifluoromethyl)benzonitrile
15. Refchem:179043
16. Shr 3680
17. Androgen Receptor Antagonist Shr3680
18. Rezvilutamida
19. Orb1691608
20. Chembl4650276
21. Schembl15506490
22. Schembl29509762
23. Gtpl12798
24. Dtxsid001336581
25. Glxc-26908
26. Akos040756903
27. (s)-4-(3-(4-(2,3-dihydroxypropoxy)phenyl)-4,4-dimethyl-5-oxo-2-thioxoimidazolidin-1-yl)-2-(trifluoromethyl)benzonitrile
28. Da-57412
29. Ms-28910
30. Hy-137448
31. Cs-0138653
32. G18393
| Molecular Weight | 479.5 g/mol |
|---|---|
| Molecular Formula | C22H20F3N3O4S |
| XLogP3 | 2.9 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 9 |
| Rotatable Bond Count | 6 |
| Exact Mass | Da |
| Monoisotopic Mass | Da |
| Topological Polar Surface Area | 129 |
| Heavy Atom Count | 33 |
| Formal Charge | 0 |
| Complexity | 791 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
40
PharmaCompass offers a list of Rezvilutamide API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Rezvilutamide manufacturer or Rezvilutamide supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Rezvilutamide manufacturer or Rezvilutamide supplier.
A Rezvilutamide manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Rezvilutamide, including repackagers and relabelers. The FDA regulates Rezvilutamide manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Rezvilutamide API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Rezvilutamide supplier is an individual or a company that provides Rezvilutamide active pharmaceutical ingredient (API) or Rezvilutamide finished formulations upon request. The Rezvilutamide suppliers may include Rezvilutamide API manufacturers, exporters, distributors and traders.
Rezvilutamide Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Rezvilutamide GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Rezvilutamide GMP manufacturer or Rezvilutamide GMP API supplier for your needs.
A Rezvilutamide CoA (Certificate of Analysis) is a formal document that attests to Rezvilutamide's compliance with Rezvilutamide specifications and serves as a tool for batch-level quality control.
Rezvilutamide CoA mostly includes findings from lab analyses of a specific batch. For each Rezvilutamide CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Rezvilutamide may be tested according to a variety of international standards, such as European Pharmacopoeia (Rezvilutamide EP), Rezvilutamide JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Rezvilutamide USP).
